Voyager Therapeutics, Inc.
VYGR
$3.77
-$0.18-4.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -39.50% | -41.89% | -40.93% | 15.51% | 36.54% |
| Total Receivables | -79.47% | -22.33% | -38.96% | -94.68% | 504.61% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -21.35% | 33.89% | 15.79% | -29.49% | 46.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 38.94% | -- |
| Total Current Assets | -41.20% | -40.28% | -40.07% | -13.41% | 42.58% |
|
|
|||||
| Total Current Assets | -41.20% | -40.28% | -40.07% | -13.41% | 42.58% |
| Net Property, Plant & Equipment | -13.46% | -13.30% | -18.61% | 58.86% | 59.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 95.34% | 0.00% | -0.55% | 80.41% | 80.41% |
| Total Assets | -32.33% | -26.16% | -24.78% | 11.89% | 44.59% |
|
|
|||||
| Total Accounts Payable | -33.04% | -30.75% | -65.25% | 149.13% | -3.36% |
| Total Accrued Expenses | 30.69% | 17.05% | 19.20% | -15.76% | 3.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.45% | 13.38% | 25.08% | 125.84% | 124.69% |
| Total Finance Division Other Current Liabilities | -53.25% | 0.00% | -58.99% | -43.11% | -48.87% |
| Total Other Current Liabilities | -53.25% | 0.00% | -58.99% | -43.11% | -48.87% |
| Total Current Liabilities | -19.71% | 4.62% | -44.58% | -22.82% | -28.33% |
|
|
|||||
| Total Current Liabilities | -19.71% | 4.62% | -44.58% | -22.82% | -28.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.45% | -19.00% | -17.69% | 113.52% | 114.12% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -81.21% | -82.38% | -59.32% | -79.01% | -66.12% |
| Total Liabilities | -28.46% | -22.47% | -37.42% | -18.85% | -19.17% |
|
|
|||||
| Common Stock & APIC | 2.61% | 2.61% | 2.64% | 25.89% | 25.91% |
| Retained Earnings | -43.46% | -38.19% | -31.08% | -24.89% | 8.15% |
| Treasury Stock & Other | 121.21% | 57.66% | 60.67% | -747.92% | 86.69% |
| Total Common Equity | -33.45% | -27.27% | -20.00% | 26.84% | 87.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -33.45% | -27.27% | -20.00% | 26.84% | 87.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -33.45% | -27.27% | -20.00% | 26.84% | 87.44% |
|
|
|||||